Paperwork Photograph
HMRN - who we are, what we do and how we do it
Pie Chart Photograph
incidence, prognosis and prevalence for all haematological cancers
Notice Board Photograph
statistics organised by individual haematological cancers
Presentation Photograph
articles, presentations, posters and reports from HMRN

What is the risk of developing a blood cancer?

Take a look at our data visualisation, produced in collaboration with Blood Cancer UK

We're recruiting!

We have two fully funded Cancer Research UK PhD studentships available. If you have an interest in epidemiology and/or statistics, particularly with a focus on cancer, we want you to join us and help us to address key research questions on occurrence, treatment and survival of patients with haematological cancers.  Applications close on the 28th February, click the link below to find out more.

New publication

We found that that people with monoclonal gammopathy of undetermined significance (MGUS) have increased hospital activity compared with the general population up to 5 years before their diagnosis. This supports the view that in some individuals monoclonal gammopathy can have severe health consequences extending over many years.

Access the HMRN members functions.


If you are a member of the Clinical Network, complete the form below to register as an HMRN user.

Confirm Email:
MDT (Multi Disciplinary Team):
I Agree to the Terms of Service:

Reset the password for your HMRN account.

Enter your username below. An email will then be sent to the address associated with your account containing a link to reset your password.


If you are unsure of your username, please contact us at

If you have any queries or comments, please feel free to contact us using the details below.

Email us

Write to us

Haematological Malignancy Research Network
Epidemiology & Cancer Statistics Group
Department of Health Sciences
Area 3
Seebohm Rowntree Building
YO10 5DD

I understand that, in accordance with the Data Protection Act 1998, by logging into this site I agree that:

  1. The data must not be published or shared with other third parties outside of the Network without first obtaining permission from the Network Audit Haematology Group.
  2. No attempt will be made to identify individual patients or to contact them and confidentiality of information will be preserved at all times.
  3. I am currently employed by an NHS trust operating in the area of the combined Yorkshire and Humber and Yorkshire Coast Cancer Networks.
  4. Any public domain reports or papers resulting from analyses of the provided data will be shared with HMRN prior to publication and appropriate acknowledgement given.